Health Canada Could Reconsider Add-On ALS Treatment Health Canada will allow AB Science to ask for reconsideration for masitinib, a treatment for amyotrophic lateral sclerosis (ALS). In an April 3 announcement, AB Science said the reconsideration process “will re-examine, with new assessors, the decision based on information that was included in the original submission.” Health…